Cargando…
Clinical guideline SEOM: cancer of unknown primary site
Cancer of unknown primary site is a histologically confirmed cancer which is manifested in advanced stage, with no identifiable primary site after the use of standard diagnostic procedures. Patients are initially placed into one of categories based upon the examination of the initial biopsy: adenoca...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239766/ https://www.ncbi.nlm.nih.gov/pubmed/25392080 http://dx.doi.org/10.1007/s12094-014-1244-0 |
_version_ | 1782345636505452544 |
---|---|
author | Collado Martín, R. García Palomo, A. de la Cruz Merino, L. Borrega García, P. Barón Duarte, F. J. |
author_facet | Collado Martín, R. García Palomo, A. de la Cruz Merino, L. Borrega García, P. Barón Duarte, F. J. |
author_sort | Collado Martín, R. |
collection | PubMed |
description | Cancer of unknown primary site is a histologically confirmed cancer which is manifested in advanced stage, with no identifiable primary site after the use of standard diagnostic procedures. Patients are initially placed into one of categories based upon the examination of the initial biopsy: adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma and poorly differentiated carcinoma. Appropriate patient management requires an understanding of several clinicopathologic features that help to identify several subsets of patients with more responsive tumors. |
format | Online Article Text |
id | pubmed-4239766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-42397662014-11-25 Clinical guideline SEOM: cancer of unknown primary site Collado Martín, R. García Palomo, A. de la Cruz Merino, L. Borrega García, P. Barón Duarte, F. J. Clin Transl Oncol Clinical Guides in Oncology Cancer of unknown primary site is a histologically confirmed cancer which is manifested in advanced stage, with no identifiable primary site after the use of standard diagnostic procedures. Patients are initially placed into one of categories based upon the examination of the initial biopsy: adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma and poorly differentiated carcinoma. Appropriate patient management requires an understanding of several clinicopathologic features that help to identify several subsets of patients with more responsive tumors. Springer Milan 2014-11-13 2014 /pmc/articles/PMC4239766/ /pubmed/25392080 http://dx.doi.org/10.1007/s12094-014-1244-0 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Clinical Guides in Oncology Collado Martín, R. García Palomo, A. de la Cruz Merino, L. Borrega García, P. Barón Duarte, F. J. Clinical guideline SEOM: cancer of unknown primary site |
title | Clinical guideline SEOM: cancer of unknown primary site |
title_full | Clinical guideline SEOM: cancer of unknown primary site |
title_fullStr | Clinical guideline SEOM: cancer of unknown primary site |
title_full_unstemmed | Clinical guideline SEOM: cancer of unknown primary site |
title_short | Clinical guideline SEOM: cancer of unknown primary site |
title_sort | clinical guideline seom: cancer of unknown primary site |
topic | Clinical Guides in Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239766/ https://www.ncbi.nlm.nih.gov/pubmed/25392080 http://dx.doi.org/10.1007/s12094-014-1244-0 |
work_keys_str_mv | AT colladomartinr clinicalguidelineseomcancerofunknownprimarysite AT garciapalomoa clinicalguidelineseomcancerofunknownprimarysite AT delacruzmerinol clinicalguidelineseomcancerofunknownprimarysite AT borregagarciap clinicalguidelineseomcancerofunknownprimarysite AT baronduartefj clinicalguidelineseomcancerofunknownprimarysite |